Progyny Reports 10% Revenue Growth in 2025, Eyes Expansion in Fully Insured Market
Event summary
- Progyny reported $1.29 billion in 2025 revenue, up 10% YoY, with Q4 revenue at $318.4 million, a 6.7% increase.
- Operating cash flow hit a record $210.2 million, with $160 million returned to shareholders via share repurchases.
- Fertility benefit services revenue grew 14% YoY, while pharmacy benefit services revenue increased 4.6% YoY.
- Progyny expects 2026 revenue between $1.355 billion and $1.405 billion, reflecting 5.1% to 9.0% growth.
- The company anticipates having approximately 600 clients and 7.2 million covered lives by the end of 2026.
The big picture
Progyny's strong 2025 performance underscores its leadership in women's health and family building solutions. The company's strategic focus on expanding its client base and entering the fully insured market positions it for continued growth, though it must navigate economic headwinds and maintain operational efficiencies to sustain its momentum. With a robust cash position and a clear path to scaling its services, Progyny is well-positioned to capitalize on the growing demand for fertility and women's health solutions.
What we're watching
- Market Expansion
- How Progyny's push into the fully insured market will impact its growth trajectory and competitive positioning.
- Client Retention
- Whether Progyny can sustain its client growth amid economic uncertainty and shifting employer priorities.
- Operational Efficiency
- The pace at which Progyny can maintain margin expansion while investing in future growth initiatives.
Related topics